SMA Stem Cell Treatment In India
In May 2019, the FDA approved onasemnogene abeparovec- xioi gene therapy for children less than 2 years old who have infantile-onset SMA. A safe virus delivers a fully functional human SMN gene to the targeted...
Explore our Clinical Research Hub for scientific publications, treatment evidence, and ongoing regenerative medicine research.
Content authored and reviewed by qualified members of our medical team | Last updated: 28 October 2022
Β© 2026 SCCI All rights reserved.